Gattex® (teduglutide) – Expanded indication
May 16, 2019 - Takeda Pharmaceuticals announced the FDA approval of Gattex (teduglutide), for the treatment of adults and pediatric patients 1 year of age and older with Short Bowel Syndrome (SBS) who are dependent on parenteral support (PS).
Download PDF
